Quantum Phar. Share Discussion Threads

[rivaldo] 23/6/2016 10:12

Doing rather nicely now. The AGM is not far away on 12th July, and then there should be an H1 trading statement in mid-august or so.

[cougar99] 17/6/2016 23:50

well it didn't hold above 70p last time ... let us see if this time is different .... down to 1p spread and a large trade reported just after closing .... so I am optimistic this time ....

[cougar99] 17/6/2016 17:18

Any thoughts on the UT transaction for GBP 230k just after closing....?

[cougar99] 15/6/2016 14:00

So, just like the Cadbury tours, then do you you get free samples during the QP tour?

[r ball] 15/6/2016 12:34

Factory tours of limited value.

[ron manager] 14/6/2016 10:05

See in the last RNS that QP are offering a site visit in late July. Extract from the statement below:

Retail Investor Days

Quantum Pharma is pleased to announce that it will be hosting two retail investor days in 2016. The first will be held at the Group's headquarters in Burnopfield, County Durham on Thursday, 28 July 2016 and will involve a presentation by Andrew Scaife (CEO) and Chris Rigg (CFO) followed by a tour of the facility and an opportunity to meet other members of the senior management team. The second investor day will be held in London at the offices of Buchanan, 107 Cheapside, London EC2V 6DN, on Wednesday, 30 November 2016 and this will involve a presentation by Andrew Scaife (CEO) and Chris Rigg (CFO) followed by a question and answer session.

No new material information will be made available on either of the retail investor days and copies of the presentations will be made available via the Group's investor relations website on the day of each meeting.

To register interest and receive further information on either proposed date, please email your details through to [e-mail] before 20 July 2016. Places will be limited and will be offered on a first come, first served basis.

DYOR

Ron

[rosejs2] 09/6/2016 19:02

There Is still I believe a hidden stakebuilder in QP shares... The 140K transaction is one of a number of what I might call 'Interesting' trades... Sometimes a flurry of AT trades .. possibly to keep as declan states the share price down...A large buy order is (I Believe)in place at a set price and MM;s will do nearly anything to fulfill..It might just be coincidence that the approved Bio Dose is now being launched .. What might a Pharma or similar company give to get it hands on it !!!!Interesting times ahead..

[davr0s] 09/6/2016 18:39

140k shares paid over the ask and we still couldn't end up. Feel these have based now so not worrying about them

[r ball] 02/6/2016 19:30

bd2 and soI am

[davr0s] 01/6/2016 19:50

A lot of buys today for little progress..

[busterdog2] 01/6/2016 14:09

You said you'd be happy with 70p by June. Apparently not.

[r ball] 01/6/2016 12:32

execution risk

[rivaldo] 01/6/2016 12:21

Good news today.

The major Biodose contract won last September with the Yorkshire and Humber NHS should help drive Biodose Connect take-up nicely.

[g2theary] 01/6/2016 08:24

Looks like a few late starters .. I'm on holiday in the Maldives so been up 5 hours now and on my 4th beer ? I have 6000 shares here that I bought at 73p last week... Watched these for a year.. Onwards and upwards from hear imo...

[g2theary] 01/6/2016 08:06

Fairly good news not a snippet of activity?

[busterdog2] 01/6/2016 08:00

Andrew Scaife, Chief Executive of Quantum Pharma Plc, commented: "We are delighted that our Biodose Connect® device now has Class I medical device status and we can start to commercialise it. It is an exciting product that we believe will provide a huge benefit to the NHS, social care providers and pharmaceutical companies, not only by reducing the burden created by medication non-adherence, but also in allowing patients to be treated at home. We look forward to bringing Biodose Connect® to the market and showcasing its strong benefits."

[maccamcd] 01/6/2016 07:57

Quantum Pharma (Corp) - Biodose Connect, the innovative telemedicine product, has received its CE Mark and will now be launched commercially. It's a soft launch, so no immediate change to forecasts, but management believes it could be a significant medium term value driver with potential customers ranging from pharmacy chains to pharma companies as well as the NHS itself. International licensing opportunities have also been mentioned in the past. These would all be upside to our forecasts.

from singers

[maccamcd] 01/6/2016 07:56

there's news out in QP that hasn't populated on advfn..